Companies: 10,795·Total market cap: $144.5T
BioLife Sciences Inc.

BioLife Sciences Inc.

BLFEOTCHealthcare● Active
$0.00
$-0.00(-0.00%)
Market Cap$156683
P/E Ratio—
52W High$0.0001
52W Low$0.000099999997
Overview

BioLife Sciences Inc. (BLFE) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

BLFE · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
51.8M▲ +166.21% YoY Change
FY · as of Nov 30, 2020 · Reported in USD
vs 19.5M in FY 2019
Diluted Shares Outstanding
51.8M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+166.21%
year-over-year
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+126.6%
2017 → 2020
5-Year CAGRincreasing
+161.8%
2015 → 2020
10-Year CAGRincreasing
+93.6%
2010 → 2020
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2020Latest
Diluted Shares: 51.8M
51.8M
+166.21%
FY 2019
Diluted Shares: 19.5M
19.5M
+0.00%
FY 2018
Diluted Shares: 19.5M
19.5M
+337.08%
FY 2017
Diluted Shares: 4.5M
4.5M
+956.35%
FY 2016
Diluted Shares: 421,263
421,263
+0.00%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs BLFE
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
BioLife Sciences Inc.BLFE
BioLife Sciences Inc.YOU
51.8M—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

BioLife Sciences Inc. (BLFE) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of November 30, 2020, BioLife Sciences Inc. reports 51.8M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

BioLife Sciences Inc.'s basic shares outstanding (51.8M) represents currently issued shares. Diluted shares outstanding (51.8M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

BioLife Sciences Inc.'s float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

BioLife Sciences Inc. (BLFE) shares outstanding history from 2002 to 2020. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

BioLife Sciences Inc. shares outstanding for the fiscal year ending November 30, 2020 were 51.8M, a 166.21% increase year-over-year. BioLife Sciences Inc. FY 2020 shares outstanding were 51.8M, a +166.21% increase from FY 2019.

BioLife Sciences Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +93.6% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

BLFE shares outstanding · 4 questions

As of November 30, 2020, BioLife Sciences Inc. (BLFE) has approximately 51.8M basic shares outstanding and 51.8M diluted shares outstanding. This represents a +166.21% year-over-year increase from FY 2019 (19.5M). The increase may reflect equity compensation issuances or secondary offerings.

BLFE shares outstandinghow many shares does BLFE haveBLFE basic shares 2020BLFE diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · BioLife Sciences Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09